Adverum Biotechnologies
ADVM
ADVM
92 hedge funds and large institutions have $85.9M invested in Adverum Biotechnologies in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 42 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
28% less capital invested
Capital invested by funds: $119M → $85.9M (-$33M)
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
69% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 42
Holders
92
Holding in Top 10
2
Calls
$2.47M
Puts
$321K
Top Buyers
| 1 | +$14.2M | |
| 2 | +$724K | |
| 3 | +$540K | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$341K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$317K |
Top Sellers
| 1 | -$9.6M | |
| 2 | -$2.03M | |
| 3 | -$1.71M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$928K |
| 5 |
Two Sigma Advisers
New York
|
-$519K |